Skip to content
OpenCapital
Get started

Globus Medical GMED Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Medtronic logo
MedtronicMDT
——
Solventum logo
SolventumSOLV
——
Fortive logo
FortiveFTV
——
Baxter International logo
Baxter InternationalBAX
——
Align Technology logo
Align TechnologyALGN
——
Teledyne Technologies logo
Teledyne TechnologiesTDY
——

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's allowance for doubtful accounts receivable (current)?
Globus Medical (GMED) reported allowance for doubtful accounts receivable (current) of $40.93M in Q1 2026.
How has Globus Medical's allowance for doubtful accounts receivable (current) changed year-over-year?
Globus Medical's allowance for doubtful accounts receivable (current) increased by 382.2% year-over-year, from $8.49M to $40.93M.
What is the long-term trend for Globus Medical's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Globus Medical's allowance for doubtful accounts receivable (current) has grown at a 50.0% compound annual growth rate (CAGR), from $4.41M to $33.43M.